138 related articles for article (PubMed ID: 28611476)
1. Primary sclerosing cholangitis: Ursodeoxycholic acid derivative: safe and effective.
Dickson I
Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):386. PubMed ID: 28611476
[No Abstract] [Full Text] [Related]
2. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares RodrÃguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
6. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
Rudolph G; Kloeters-Plachky P; Rost D; Stiehl A
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid in primary sclerosing cholangitis.
Triantos CK; Koukias N; Nikolopoulou V; Burroughs AK
Aliment Pharmacol Ther; 2012 Mar; 35(5):622-3. PubMed ID: 22300127
[No Abstract] [Full Text] [Related]
8. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
Christensen KL; Andersen BN; Vilstrup H
Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
[TBL] [Abstract][Full Text] [Related]
10. The medical management of primary sclerosing cholangitis.
Cullen SN; Chapman RW
Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
[TBL] [Abstract][Full Text] [Related]
11. Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis.
Santander C; Moreno-Otero R
Aliment Pharmacol Ther; 2012 Apr; 35(7):846; discussion 847. PubMed ID: 22404405
[No Abstract] [Full Text] [Related]
12. Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
Chapman RW
Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):74-5. PubMed ID: 20134486
[No Abstract] [Full Text] [Related]
13. Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?).
Tabibian JH; Lindor KD
Hepatology; 2014 Sep; 60(3):785-8. PubMed ID: 24752961
[No Abstract] [Full Text] [Related]
14. Primary sclerosing cholangitis: providing a safe and effective treatment.
Imam MH; Lindor KD
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):255-7. PubMed ID: 22646247
[No Abstract] [Full Text] [Related]
15. Medical therapy for primary sclerosing cholangitis.
Wong GL; Wong VW
Aliment Pharmacol Ther; 2011 Nov; 34(9):1135-6; discussion 1136-7. PubMed ID: 21981734
[No Abstract] [Full Text] [Related]
16. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
Zimmer V; Lammert F
EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
[No Abstract] [Full Text] [Related]
17. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
18. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
Boner AL; Peroni D; Bodini A; Delaini G; Piacentini G
Int J Immunopathol Pharmacol; 2007; 20(4):847-9. PubMed ID: 18179759
[TBL] [Abstract][Full Text] [Related]
19. [Cholestasis: therapeutic options].
Beuers U; Oswald M
Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and medical therapy of primary sclerosing cholangitis.
van Milligen de Wit AW
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
[No Abstract] [Full Text] [Related]
[Next] [New Search]